<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Many factors have been implicated in the etiology of cerebral venous sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> (CVT) </plain></SENT>
<SENT sid="1" pm="."><plain>These include head injury, <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> (<z:hpo ids='HP_0100806'>sepsis</z:hpo>, <z:hpo ids='HP_0000246'>sinusitis</z:hpo>, and <z:hpo ids='HP_0000265'>mastoiditis</z:hpo>), <z:hpo ids='HP_0003256'>coagulopathies</z:hpo>, pregnancy, <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo>, and <z:hpo ids='HP_0001944'>dehydration</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>CASE SUMMARY: We present the case of a patient who received long-term <z:chebi fb="0" ids="50114">estrogen</z:chebi> therapy for approximately 15 years after feminizing genitoplasty </plain></SENT>
<SENT sid="3" pm="."><plain>The patient experienced a CVT with an excellent clinical outcome </plain></SENT>
<SENT sid="4" pm="."><plain>A similar case has not been reported in the literature </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: Because CVT may be associated with morbidity, mortality, and risks from the complications and treatments of the condition, further research is needed to clarify the factors that may contribute to the long-term risk of CVT in patients receiving long-term <z:chebi fb="0" ids="50114">estrogen</z:chebi> therapy after feminizing genitoplasty </plain></SENT>
</text></document>